Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $756.33 | 16 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $390.72 | 13 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $365.61 | 3 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $20.04 | 1 | Otsuka America Pharmaceutical, Inc. ($20.04) |
| 2023 | $73.25 | 4 | Otsuka America Pharmaceutical, Inc. ($73.25) |
| 2022 | $145.92 | 5 | Otsuka America Pharmaceutical, Inc. ($145.92) |
| 2021 | $517.12 | 6 | Neurocrine Biosciences, Inc. ($365.61) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/14/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: PSYCHIATRY | ||||||
| 11/06/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: PSYCHIATRY | ||||||
| 10/02/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: PSYCHIATRY | ||||||
| 07/11/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: PSYCHIATRY | ||||||
| 03/27/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: PSYCHIATRY | ||||||
| 11/29/2022 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: PSYCHIATRY | ||||||
| 10/27/2022 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $72.59 | General |
| Category: PSYCHIATRY | ||||||
| 10/19/2022 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: PSYCHIATRY | ||||||
| 04/30/2022 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: PSYCHIATRY | ||||||
| 02/02/2022 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: PSYCHIATRY | ||||||
| 12/16/2021 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $120.98 | General |
| Category: PSYCHIATRY | ||||||
| 12/02/2021 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $115.58 | General |
| Category: NEUROLOGY | ||||||
| 11/12/2021 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $131.14 | General |
| Category: NEUROLOGY | ||||||
| 10/11/2021 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.37 | General |
| Category: PSYCHIATRY | ||||||
| 09/24/2021 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $118.89 | General |
| Category: NEUROLOGY | ||||||
| 05/05/2021 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $9.16 | General |
| Category: PSYCHIATRY | ||||||
About Nancy Mitchell
Nancy Mitchell is a Psychiatric/Mental Health, Child & Adolescent healthcare provider based in Glastonbury, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/05/2007. The National Provider Identifier (NPI) number assigned to this provider is 1265561195.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Nancy Mitchell has received a total of $756.33 in payments from pharmaceutical and medical device companies, with $20.04 received in 2024. These payments were reported across 16 transactions from 2 companies. The most common payment nature is "Food and Beverage" ($756.33).
Practice Information
- Specialty Psychiatric/Mental Health, Child & Adolescent
- Other Specialties Child & Adolescent
- Location Glastonbury, CT
- Active Since 03/05/2007
- Last Updated 01/20/2017
- Taxonomy Code 364SP0807X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1265561195
Products in Payments
- INGREZZA (Drug) $365.61
- REXULTI (Drug) $197.15
- ABILIFY MAINTENA (Drug) $193.57
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.